1. Löhr JM, Vujasinovic M, Rosendahl J, Stone JH, Beuers U. 2022; IgG4-related diseases of the digestive tract. Nat Rev Gastroenterol Hepatol. 19:185–197. DOI:
10.1038/s41575-021-00529-y. PMID:
34750548.
3. Moon SH, Kim MH. 2022; Autoimmune pancreatitis and immunoglobulin G4-related sclerosing cholangitis: Past, present, and future. Korean J Gastroenterol. 80:107–114. DOI:
10.4166/kjg.2022.102. PMID:
36156034.
4. Umehara H, Okazaki K, Kawa S, et al. 2021; The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol. 31:529–533. DOI:
10.1080/14397595.2020.1859710. PMID:
33274670.
5. Wallace ZS, Naden RP, Chari S, et al. 2020; The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-related disease. Arthritis Rheumatol. 72:7–19. DOI:
10.1002/art.41120. PMID:
31793250.
6. Umehara H, Okazaki K, Nakamura T, et al. 2017; Current approach to the diagnosis of IgG4-related disease - Combination of comprehensive diagnostic and organ-specific criteria. Mod Rheumatol. 27:381–391. DOI:
10.1080/14397595.2017.1290911. PMID:
28165852.
7. Löhr JM, Beuers U, Vujasinovic M, et al. 2020; European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. United European Gastroenterol J. 8:637–666. DOI:
10.1177/2050640620934911. PMID:
32552502. PMCID:
PMC7437085.
8. Watanabe A, Goto T, Kamo H, et al. 2018; Resection of lesions in the ileum of patients with IgG4-related disease may ameliorate disease progression without steroid administration. Surg Case Rep. 4:148. DOI:
10.1186/s40792-018-0546-9. PMID:
30594958. PMCID:
PMC6311175.
9. Lee HW, Moon SH, Kim MH, et al. 2018; Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment. J Gastroenterol. 53:967–977. DOI:
10.1007/s00535-018-1434-6. PMID:
29362937.
10. Shiokawa M, Kodama Y, Yoshimura K, et al. 2013; Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 108:610–617. DOI:
10.1038/ajg.2012.465. PMID:
23318486.
11. Hart PA, Law RJ, Dierkhising RA, Smyrk TC, Takahashi N, Chari ST. 2014; Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature. Pancreas. 43:417–421. DOI:
10.1097/MPA.0000000000000053. PMID:
24622072.
12. Lee KW, Chang JH, Kim J, et al. 2020; Metachronous development of peritoneal carcinomatosis in a patient with autoimmune pancreatitis. Korean J Gastroenterol. 75:356–361. DOI:
10.4166/kjg.2020.75.6.356. PMID:
32581208.
13. Wong DD, Pillai SR, Kumarasinghe MP, et al. 2012; IgG4-related sclerosing disease of the small bowel presenting as necrotizing mesenteric arteritis and a solitary jejunal ulcer. Am J Surg Pathol. 36:929–934. DOI:
10.1097/PAS.0b013e3182495c96. PMID:
22367294.
14. Ko Y, Woo JY, Kim JW, et al. 2013; An immunoglobulin G4-related sclerosing disease of the small bowel: CT and small bowel series findings. Korean J Radiol. 14:776–780. DOI:
10.3348/kjr.2013.14.5.776. PMID:
24043971. PMCID:
PMC3772257.
15. Ciccone F, Ciccone A, Di Ruscio M, et al. 2018; IgG4-related disease mimicking Crohn's disease: A case report and review of literature. Dig Dis Sci. 63:1072–1086. DOI:
10.1007/s10620-018-4950-6. PMID:
29417330.
16. Campos-Murguía A, Martinez-Garcia CL, Chable-Montero F, Zamora-Nava LE. 2023; Multifocal ulcerating stenosing enteritis as a novel manifestation of immunoglobulin G4-related disease. Endoscopy. 55(S 01):E163–E164. DOI:
10.1055/a-1952-0490. PMID:
36307068. PMCID:
PMC9829813.
17. Fujita K, Naganuma M, Saito E, et al. 2012; Histologically confirmed IgG4-related small intestinal lesions diagnosed via double balloon enteroscopy. Dig Dis Sci. 57:3303–3306. DOI:
10.1007/s10620-012-2267-4. PMID:
22695887.
18. Hiyoshi Y, Oki E, Zaitsu Y, et al. 2014; IgG4-related disease of the ileocecal region mimicking malignancy: A case report. Int J Surg Case Rep. 5:669–672. DOI:
10.1016/j.ijscr.2014.08.003. PMID:
25194601. PMCID:
PMC4189076.